Janssen, the pharmaceutical companies of Johnson & Johnson, today announced a first-of-its-kind pediatric HIV treatment donation program to improve access to the company's approved HIV medicines for children and adolescents failing HIV treatment in sub-Saharan Africa.
http://www.news-medical.net/news/20131209/Janssen-announces-first-of-its-kind-pediatric-HIV-treatment-donation-program.aspx
http://www.news-medical.net/news/20131209/Janssen-announces-first-of-its-kind-pediatric-HIV-treatment-donation-program.aspx
No comments:
Post a Comment